Identification of pericentriolar matrix protein 1 (PCM1) as a novel scaffold for Protein Kinase A (PKA) and NIMA-related kinase 10 (NEK10) by Porpora, Monia
 1 
 
UNIVERSITA’ DEGLI STUDI DI NAPOLI 
"FEDERICO II" 
 
 
 
    TESI DI DOTTORATO IN 
PATOLOGIA E FISIOPATOLOGIA MOLECOLARE 
XXVI° CICLO 
 
 
Identification of pericentriolar matrix protein 1 
(PCM1) as a novel scaffold for Protein Kinase A 
(PKA) and NIMA-related kinase 10 (NEK10). 
 
COORDINATORE    CANDIDATA 
Ch.mo Prof. V. E. Avvedimento                      Dott.ssa Monia Porpora 
 
 
SUPERVISORE 
Ch.mo Prof. Antonio Feliciello 
ANNO ACCADEMICO 2013/2014 
 
 2 
 
CONTENTS.………………………………………………….………………………………………………….………...2 
 
ORIGINAL PUBBLICATIONS ............................................................................................. 4 
 
ABSTRACT ....................................................................................................................... 5 
 
INTRODUCTION .............................................................................................................. 7 
 
1.1 The cAMP-dependent signal transduction pathway................................................ 8 
1.2 Protein Kinase A (PKA) ........................................................................................... 11 
1.3  AKAP proteins ....................................................................................................... 16 
1.4  Pericentriolar  Material 1 (PCM1) ......................................................................... 21 
1.5  PCM1 and ciliogenesis ........................................................................................... 24 
1.6 NimA related kinase 10  (Nek10) ........................................................................... 26 
 
AIM OF THE STUDY ...................................................................................................... 30 
 
RESULTS ....................................................................................................................... 33 
2.1 PCM1 and RIIβ form a stable complex ................................................................... 34 
2.2  Endogenous PCM1 and RIIβ colocalize in Human Embryonic Kidney 293 cells. ... 36 
 3 
 
2.3  Mapping the PKA binding domain on PCM1 ......................................................... 38 
2.4  PCM1  is an A-Kinase Anchor Protein ................................................................... 40 
2.5 PCM1 silencing redistributes endogenous RIIβ subunits ....................................... 42 
2.6PCM1 interacts with NimA related kinase 10, Nek10 ............................................. 44 
2.7  Mapping the NEK10 binding domain on PCM1 ..................................................... 46 
2.8. PCM1, NEK10 and RIIβ colocalize at the Golgi-centrosome region ...................... 48 
2.9 PKA regulates phosphorylation and binding of NEK10 to PCM1 ........................... 50 
2.10  NEK10 controls primary cilium formation........................................................... 56 
 
DISCUSSION .................................................................................................................. 58 
 
METHODS ..................................................................................................................... 63 
 
REFERENCES ................................................................................................................. 68 
 
  
 4 
 
ORIGINAL PUBBLICATIONS 
 
1. Carlucci A, Porpora M, Garbi C, Galgani M, Santoriello M, Mascolo M, di 
Lorenzo D, Altieri V, Quarto M, Terracciano L, Gottesman ME, Insabato L, 
Feliciello A. (2010)  PTPD1 supportsreceptorstability and 
mitogenicsignaling in bladdercancercells. J BiolChem. 
 
 
 
 
 
  
 5 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
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The pericentriolar material 1 (PCM1) assembles a molecular platform around the 
pericentriolar matrix and centrosome that is essential for cell division and 
microtubule dynamics, and plays a critical role in different aspects of mitosis and 
ciliogenesis.  
Here, we report an additonal layer of complexity and found that PCM1 nucleates a 
signaling complex at the pericentriolar matrix, which includes PKA and NEK10. By co-
clustering two distinct signaling enzymes, PCM1 controls critical aspects of 
mammalian ciliogenesis. Within the PCM1 complex, PKA regulates NEK10 localization 
and  stability, efficiently coupling cAMP signaling to the ubiquitin-proteasome system 
(UPS). In this context, PCM1 acts as relay that senses, transmits and integrates cAMP 
and mitogenic signals generated at cell membrane, regulating biological events at the 
pericentriolar matrix area and primary cilium. 
The molecular characterization of relevant protein complexes at specific sub-cellular 
compartments and understanding the role of scaffold platform in critical aspects of 
cell biology will likely contribute to the design of novel therapeutic approaches for 
human diseases. 
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1.1 The cAMP-dependent signal transduction pathway 
 
Living cells are exposed to many processes and functions that allow the 
organism to respond and adapt itself to different conditions and needs. To 
make this possible it is necessary that each cell is capable of responding to 
different signals translating implementation or shutting down of specific 
mechanism. There are many molecules that act like extracellular messengers, 
such as hormones, neurotransmitters and growth factors, that regulate a 
different cellular processes, as cellular differentiation and division, ionic 
channels activity, gene transcription and protein translation.  
The binding of these molecules to specific cellular receptors elicits cellular 
responses. Plasma membrane receptors transmit the signals of the specific 
hydrophilic messengers, generating biophysical modification or increasing 
intracellular signalling molecules concentration known as second messengers. 
The first second messenger identified is the cyclic AMP (cAMP) (Sutherland et 
al., 1970). cAMP-dependent transduction pathway is mediated by G-coupled 
receptors that activate the adenylyl cyclase (AC), ubiquitous enzyme 
converting ATP  in cAMP. In mammals, the ubiquitous second messenger 
cAMP is synthesized by two classes ofAC: the G protein responsive 
transmembrane adenylyl cyclases (tmACs) and the widely distributed, 
bicarbonate-responsive, soluble adenylyl cyclase (sAC) (Chen et al., 2000). 
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tmACs are characterized by a short NH2-terminal amino-acidic segment and 
by two cytoplasmic domains (C1 and C2) separated by two highly hydrophobic 
transmembrane domains (M1 and M2).  C1 and C2 constitute catalytic site of 
adenylyl cyclase. 
cAMP mediates its cellular effects via at least three distinct classes of direct 
effectors; cAMP-dependent protein kinase (PKA), RAP exchange proteins 
(EPACs), and cAMP gated ion channels (cNGC). cNGCs and a subset of PKA 
targets are localized to the plasma membrane, near tmACs, in what appear to 
be macromolecular signaling complexes comprising the G protein coupled 
receptor, G protein, tmAC, and PKA and its ultimate substrate (Zippin et al., 
2002) (Fig. 1) 
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Figure 1. Schematic diagram of cAMP synthesis and downstream effector activation. 
When an extracellular ligand such as an hormone binds to and activates a seven-
transmembrane G-protein-coupled receptor, the signal is passed through the 
heterotrimeric G protein to adenylyl cyclase. The activated adenylyl cyclase converts 
ATP into the second messenger cAMP. As the gradient of cAMP concentration 
diffuses in the cell, various enzymes or effectors are activated. 
These include PKA, PDE and EPAC. The interplay of each of these effectors as they 
interact directly or indirectly with each other and other downstream targets is 
currently an area of intense study. 
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1.2 Protein Kinase A (PKA)  
 
Activation of PKA is solely accomplished by the major, diffusible secondary 
messenger cAMP (Su et al., 1995).PKA Holoenzyme is a serine/threonine 
kinase constitutes by two catalytic subunits (PKAc or C) that are helded in an 
inactive complex by a dimer of regulatory subunits (Rs).Binding of cAMP to 
each R subunit relieves the autoinhibitory contact, allowing the C subunits to 
dissociate (Wang et al., 1991) thereby resulting in phosphorylation of local 
substrates (fig. 2).PKA-dependent phosphorylation of nuclear and cytoplasmic 
substrates controls multiple cell functions, including motility, metabolism, 
differentiation, synaptic transmission, ion channel activities, growth and 
coordinate gene transcription (Edelman et al., 1987; Taylor et al., 1992; 
Meinkoth et al., 1993; Montminy et al., 1997). 
Two forms of the heterotetrameric PKA holoenzyme exist: type I (RI and RI 
dimer) and type II (RII and RII dimer). Type I PKA is predominantly 
cytoplasmic, whereas type II PKA associates with specific cellular structures 
and organelles. Catalytic subunits are encoded from three different genes Cα, 
Cβ e Cγ, that show common kinetic features and substrate specificity (Taylor 
et al., 1992).Four genes encode the R subunits R1α, R1β, R2α e R2β(Taylor et 
al., 1992), that confer the different biochemical and biological characteristics 
to the PKA isoforms. The R subunit is a modular polypeptide containing an 
 12 
 
NH2-terminal dimerization domain, an autophosphorylation site that serves as 
a principal contact site for the C subunit, and two cAMP binding sites.  
The R subunits are differentially distributed in mammalian tissues. RI and 
RII are ubiquitous, whereas RII is expressed predominantly in endocrine, 
brain, fat and reproductive tissues (Edelman et al., 1987; Taylor et al., 1992).In 
addition to their distinctive expression and distribution, R subunits differ in 
their regulation and biochemical properties. The binding affinity to cAMP of 
RII in vivo is lower relative to RII and much lower compared to RI(Edelman 
et al., 1987; Taylor et al., 1992).  
However, there are many AKAPs that bind RIIsubunits  in a specific manner. 
These data imply that holoenzymes containing RI subunits or RII subunits 
(PKAI and PKAII) decode cAMP signals that differ in duration and intensity: 
PKAI is activated transiently by weak cAMP signals, whereas PKAII responds to 
high and persistent cAMP stimulation. Neurons and endocrine cells, which 
express predominantly PKAII, are adapted to persistent high concentrations of 
cAMP(Stein et al., 1987). The specific biochemical properties of PKA isozymes 
account, in part, for the differential cellular responses to discrete extracellular 
signals that activate adenylyl cyclase. 
The function(s) in vivo of the specific PKA isoforms in gene expression and cell 
signaling has been probed using knockout (KO) and transgenic mouse models 
(Brandon et al., 1995a).Ablation of the gene encoding the RI tether to 
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deficits in hippocampal long-term depression and depotentiation (Qi et al., 
1996; Brandon et al., 1995b). Despite a compensatory increase in total PKA 
activity, in the RI KO mice, hippocampal function is impaired, suggesting a 
unique role for RI in synaptic plasticity (Amieux et al., 1997). A targeted 
disruption of the RII gene yields viable mice with no physiological 
abnormalities, implying that PKAI and/or PKAII compensates for the RII 
defect (Burton et al., 1997, 1999).Targeted disruption of the mouse RII gene 
has additional physiological consequences. The mutant mice are lean and 
have elevated metabolic rates caused by increases in both basal PKA activity 
and the basal rate of lipolysis (Cummings et al., 1996; McKnight et al., 
1998).RII KO mice also display defects in neuronal gene expression, learning 
and behavior (Adams et al., 1997; Brandon et al., 1998).  
Living cells developed several regulation system to control the effects of the 
cAMP/PKA signaling pathway. Termination of cyclic-nucleotide signaling is 
achieved by PDEs, a superfamily of >70 different isozymes that degrade cAMP 
and cyclic GMP (cGMP). Distinctive tissue distribution, subcellular 
compartmentalization and differential regulation of these enzymes contribute 
to the establishment of local cAMP gradients by limiting the diffusion of cAMP 
that is generated by adenylyl cyclases (Houslay et al., 2003).The type-4 PDEs 
are a family of  >16 distinct isoforms that have a conserved catalytic core. 
Divergence within the N-terminal region of PDE4 isoforms enables association 
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with various proteins and, therefore, differential subcellular targeting and 
regulation. Importantly, the PDE4D3 isozyme has been shown to be part of 
signaling complexes that target PKA.  
The action of PKA, as with many other serine/threonine kinases, is 
counterbalanced by specific protein phosphatases. In some cases, it has been 
demonstrated that phosphatases belonging to the PP1 and PP2A families are 
responsible for dephosphorylation of PKA substrates. In turn, PKA can control 
phosphatase activity by phosphorylation of specific PP1 inhibitors, such as I-1 
and DARPP32 (Fimia et al., 2000). 
PKA is targeted at specific intracellular microdomains through interactions 
with A-Kinase-Anchor-Proteins (AKAPs). AKAP forms a local transduction unit, 
which includes different signalling/metabolic enzymes, receptors, ion 
channels, adaptor molecules and mRNAs. In this context, the spatio-temporal 
kinase activation provides a control mechanism to direct, integrate and locally 
attenuate the cAMP cascade. 
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Figure 2. PKA molecular structure and activation mechanism. 
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1.3  AKAP proteins 
 
Subcellular targeting through association with anchoring proteins has 
emerged as an important mechanism by which the cells localize signalling 
enzymes to sites where they can be accessed optimally by activators and, in 
turn, interact with particular substrates. The PKA is  concentrated in 
particulate membranes and cellular organelles through interaction with a 
family of non-enzymatic scaffold proteins: AKinase Anchor Proteins (AKAPs) 
(Rubin, 1994; Edwards & Scott, 2000; Dodge & Scott, 2000). 
AKAPs are a group (> 50 proteins) of functionally, rather then structurally, 
related proteins and each contains  a common RII-binding site  formed by 14–
18 amino acid amphipathic aligned  along one face of the helix and charged 
residues and the other side, that bind amino termini of PKA-RII dimer (Carr et 
al., 1991; Newlon et al., 1999) (Fig. 3).The first 30 amino acid residues of RII 
participate in AKAP binding, as shown by site-directed mutagenesis, 
biochemical analysis and solid-phase binding assays (Li & Rubin, 1995; 
Hausken et al., 1994, 1996). These residues also promote dimerization of RII 
subunits, which is a prerequisite for binding to AKAP. Although most AKAPs 
that have been characterized to bind to RII subunits with high affinity, several 
AKAPs have been reported to interact specifically with RI. 
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RII subunits bind to AKAPs with nanomolar affinity, by contrast, RI subunits 
bind to AKAPs with only micromolar affinity. However D-AKAP1 and D-AKAP2 
are examples of dual-specificity AKAPs that can anchor both types of R subunit 
(Huang et al., 1997; Wang et al., 2001). 
Structural data indicate that there is a single region of multiple contact sites 
between the RII subunit dimer and the AKAP, which presumably for the high-
affinity interaction. Functionally, this suggests that the AKAP–PKA complex is 
likely to be a constitutive interaction in cells and not subject to regulation. 
However, the distribution of the PKA holoenzyme can be altered upon 
induction of AKAP expression. Thereby, regulation of PKA localization might 
be a function of AKAP targeting. 
Each AKAP also contains a subcellular targeting domain that restricts its 
localization within the cell. A combination of subcellular-fractionation and 
immunohistochemical studies have identified AKAPs in association with a 
variety of cellular compartments, including centrosomes, dendrites, 
endoplasmic reticulum, mitochondria, nuclear membrane, plasma membrane 
and vesicles. Although AKAPs have been defined on the basis of their 
interaction with PKA, an additional feature of many of these molecules is their 
ability to bind to other signalling enzymes, such as protein phosphatases and 
kinases. AKAPs form a multiproteic complex with the presence of signal 
transduction and signal termination enzymes in the same network. This 
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creates focal points of enzyme activity where the bidirectional regulation of 
signaling events can be controlled and the phosphorylation status of target 
substrates is precisely regulated. (Feliciello et al., 2001) 
AKAP forms a ``transduceosome'' by acting as an autonomous multivalent 
scaffold that assembles and integrates signals derived from multiple 
pathways. The transduceosome amplifies cAMP and other signals locally and, 
by stabilizing and reducing the basal activity of PKA, it also exerts long-
distance effects. The AKAP transduceosome thus optimizes the amplitude and 
the signal/noise ratio of cAMP-PKA stimuli travelling from the membrane to 
the nucleus and other subcellular compartments (Feliciello et al., 2001). 
Importantly, besides kinase and phosphatase, reports have demonstrated that 
phosphodiesterases, the enzymes that catalyze cAMP metabolism, are 
present in complex with AKAP and PKA. These findings add a novel twist to 
PKA regulation, as they indicate that an anchored pool of phosphodiesterase 
may tightly control local cAMP levels. 
AKAPs, anchoring the PKA in close proximity of the substrates, optimize the 
PKA-dependent phosphorylation of a plethora of cellular substrates.  
Cells that express high levels of membrane-bound PKA are more sensitive the 
cAMP increase  (Feliciello et al., 1998, Feliciello et al., 2000).This might be 
explained by the fact that membrane-bound PKA is more stable than the 
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cytosolic enzyme (Feliciello et al., 1996). PKA levels are higher in cells 
containing a high fraction of membrane-bound PKA, and the effects of PKA 
activation are more readily transmitted from the point of cAMP generation at 
the cell membrane (Lester et al., 1997; Paolillo et al., 1999; Cassano et al. 
1999). 
This interaction between AKAPs and cAMP, defines a positive regulatory loop 
in which the second messenger stimulates AKAP expression that in turn 
enhances cAMP dependent signaling pathway.In this way anchor proteins are 
involved in a potent regulatory mechanism that, coordinating and integrating 
several cellular processes, controls the specificity of signal transduction. 
In higher eukaryotes, essential functions such as neurite outgrowth and 
morphogenesis, synaptic transmission, hormones production and release, 
require tightly regulated response to PKA stimulation. 
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Figure 3. Consensus sequence of AKAP-RII-binding domains.  
Consensus sequence derived from the alignment of the primary sequences of several 
AKAPs (upper). The amphipathic helical wheel and the residues forming it are 
depicted as a thick line (lower). 
  
 21 
 
1.4  Pericentriolar  Material 1 (PCM1) 
 
In mammalian cells, the centrosomes are most important because it is a major 
microtubule organizing center (MTOC). A centrosome is composed of two 
orthogonal centrioles, which are surrounded by an electron dense amorphous 
cloud of pericentriolar matrix, often abbreviated as "PCM". The PCM is 
essential for nucleation and organization of microtubules. Centriolar satellites 
are non-membranous 70–100 nm granules scattered around the centrosome 
of many types of animal cells, and similar structures also exist around the 
basal bodies(equivalent to the centrosome) of ciliated cells. PCM1was 
identified as the major component of centriolar satellites. PCM1 plays a role 
in the recruitment of centrosomal proteins including centrin, pericentrin and 
ninein, and it is required for the organization of the cytoplasmic microtubule 
network (Kim et al., 2008). PCM1 granules are formed by self aggregation of 
PCM1 in a cell cycle-dependent manner. PCM1-positivegranules were not 
necessarily concentrated around centrioles but are scattered throughout the 
cytoplasm. PCM1 granules disappear during mitosis, re-appearing when the 
cells proceed into interphase (Kubo et al., 2003). 
PCM1 gene is localized on the short arm of human chromosome 8 (8p22-
p21.3). PCM1 gene generates four known transcripts, the longest of which has 
39 exons. The 6.8 Kbp transcript encodes for a proteine of 2024 residues, with 
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an estimate weight of 228 Kda (Balczon et al., 1994). PCM1 protein contains 
coiled coil regions between areas of low complexity as well as an adenosine 
triphosphate(ATP)/GTPase domain, a nuclear localization domain and an 
eukaryotic molybdopterin domain. The centriole, when present, influences 
the organization of PCM1. For example, experimental removal of the centriole 
causes the PCM1 to disperse (Bobinnec et al., 1998), whereas reduction in the 
size of the centriole alters the amount of PCM1 associated with the 
centrosome (Kirkham et al., 2003).There is a specific subset of PCM1 proteins 
that are positioned along the surface of a mature centriole, integrating the 
PCM1 with the centriole. The spatial distribution of these proteins is retained 
throughout interphase, thus producing a stable protein array within the PCM 
at the surface of the centriole. PCM1  proteins at the surface of the centriole 
have a distribution that is directly related to the polar nature of the centriole. 
The manner in which PCM1 proteins are placed around the centriole 
integrates PCM1 function with centriole function. Centriole duplication and 
PCM1 assembly (at least in the vicinity of the centriole) are coordinated, and 
one of the hallmarks of centrosome duplication is the precise assembly of 
PCM1 proteins along the surface of the centriole (Young et al., 2004). PCM1 
forms a complex with DISC1 and BBS4 through discrete binding domains in 
each protein. DISC1 and BBS4 are required for targeting PCM1 and other 
cargo proteins, such as ninein, to the centrosome in a synergistic manner. In 
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the developing cerebral cortex, suppression of PCM1 leads to neuronal 
migration defects, which are phenocopied by the suppression of either DISC1 
or BBS4 and are exacerbated by the concomitant suppression of both 
proteins. Furthermore, a nonsense mutation that segregates with SZ spectrum 
psychosis was found in 1 family.   
The  centrosomal proteins have an important role in cortical development and  
the  perturbation of centrosomal function contributes to the development of 
mental diseases, including SZ. (Kamiya et al., 2008).Functions of the PCM1 
include microtubule nucleation from -tubulin ring complexes (Raynaud-
Messina et al., 2007), and influencing the control of centriole number 
(Loncarek et al., 2008). The expansion in size and microtubule nucleating 
capacity of the PCM1 during mitosis is influenced by a growing list of proteins, 
whose depletion or inactivation has been shown to interfere with centrosome 
maturation (Mahen et al.,2011). 
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1.5  PCM1 and ciliogenesis 
 
PCM1 is essential role for the ciliogenesis. Primary cilium is an important cell 
organelle that assembles on basal body and projects from cell surface, and 
plays critical roles in sensation and cellular signal transduction owning to the 
enrichment of receptors and channels on ciliary membrane (Berbari et al., 
2009; Singla and Reiter, 2006). The defects of primary cilia function lead to 
numerous cilium-related human diseases, such as Bardet-Biedl Syndrome 
(BBS), Joubert Syndrome(JS), retinal degeneration, polycystic kidney disease 
and other disorders (Ishikawa and Marshall, 2011). Primary cilia assemble 
when cells exit from cell cycle and enter quiescence, while the cilia of 
proliferating cells often exhibit dynamic probably due to the fact that cilia 
disassembly liberates centrioles to undergo duplication and separation for 
bipolar spindle assembly, although centriole duplication can also take place 
while the mother centriole still acts as the ciliary basal body (Fonte et al., 
1971; Quarmby and Parker, 2005; Rieder, 1979; Seeley and Nachury, 2010; 
Uetakeet al., 2007).PCM1 recruits PLK1 to the pericentriolar matrix and 
promotes primary cilia disassembly before miotic entry (Wang et al., 2012).  In 
the pericentriolar satellites regions, there are the BBS family proteins, in 
particular BBS4. BBS4 participates in ciliogenesis through interaction with 
PCM1 (Kim et al., 2004; Nachury et al., 2007). JS is  characterized by mutations 
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of CEP290 gene. CEP290 binds to PCM-1 and localizes to centriolar satellites in 
a PCM1 and microtubule-dependent manner. Depletion of CEP290 disrupts 
subcellular distribution and protein complex formation of PCM1. Down-
regulation of CEP290 disorganizes the cytoplasmic microtubule network. 
Moreover, both CEP290 and PCM-1 are essential regulators of ciliogenesis and 
are both involved in the ciliary targeting of Rab8, a small GTPase shown to 
collaborate with BBS protein complex to promote ciliogenesis (Kim et 
al.,2008). 
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1.6 NimA related kinase 10  (Nek10) 
 
Early studies in lower Eukaryotes have defined a role for the members of the 
NimA related kinase (Nek) family of protein kinases in cell cycle control(Fig.4). 
Expansion of the Nek family throughout evolution has been accompanied by 
their broader involvement in checkpoint regulation and cilia biology. 
Mutations of Nek family membershave been identified as drivers behind the 
development of ciliopathies and cancer. Recent advances in studying the 
physiological roles of Nek family members using mouse genetics and RNAi-
mediated knockdown are revealing the intricate associations of Nek family 
members with fundamental biological processes. 
Nek protein kinases begun to emerge as important regulators of the 
eukaryotic cell cycle, both during normal cell cycle progression and in 
response to genotoxic stress. NimA consists of an N-terminal catalytic domain, 
coiled-coiled domains, which mediate oligomerization, and PEST sequences, 
which participate in ubiquitin dependent  proteolysis. NimA kinase activity 
exhibits a preference for N-terminal hydrophobic residues and a 
phenylalanine at position -3 relative to the phosphorylated residue 
(FR/KR/KS/T, target residue underlined). Despite low overall sequence 
homology, the organizational features of  NimA are broadly conserved among 
mammalian Nek kinases. For instance, all Nek kinases except Nek10 contain 
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N-terminal catalytic domains, whereas Nek4, 6 and 7 are the only family 
members that do not contain coiled-coiled motifs. Moreover, 6 of 11 
mammalian Nek kinases contain putative PEST sequence. Outside regions of 
homology, certain Nek kinases contain unique protein domains that point to 
the acquisition of novel functions relative to the ancestral NimA protein. 
Additional unique domains in Nek family members include a predicted DEAD-
box helicase-like domain in Nek5 and a cluster of armadillo repeats in Nek10. 
In addition to the established functions during mitosis, certain Nek kinases 
also participate in cell cycle regulation following genotoxic stress. All 
eukaryotic cells have multiple molecular mechanisms to identify and repair 
damaged DNA and preserve genomic integrity. An important aspect of this 
process is the activation of a checkpoint with concomitant induction of cell 
cycle arrest, that would favor repair damaged DNA. Cell cycle arrest can be 
triggered at G1/S, intra-S and at G2/M phases of the cell cycle following 
damage caused by endogenous sources, such as stalled replication forks, or by 
exogenous agents, including ultraviolet (UV) radiation, ionizing radiation (IR), 
reactive oxygen species (ROS) and certain chemotherapeutic agents. Upon 
successful repair, the cell will re-enter the cell cycle.  
Nek10, a previously uncharacterized Nek family member, has uncovered its 
role in G2/M checkpoint control. In response to UV irradiation, HEK293 and 
MCF10A cells depleted for Nek10 displayed an impaired G2/M arrest.  
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Figure4. Alignment of the key structural features of the 11 mammalian NIMA-related 
kinases. The relative positions of significant motifs and regions are indicated (Moniz 
et al., 2011) 
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Nek10 gene localizes on the short arm of human chromosome 3 (3p24.1). This 
gene encodes for fourteen transcripts, the longest of which has 39 exons. The 
4.25 Kbp transcript encodes a protein of 1172 residues, with an estimate 
weight of  133 Kda. NEK10 is required for the activation of extracellular signal-
regulated kinase 1/2 (ERK1/2) signaling upon UV irradiation, but not in 
response to mitogens, such as epidermal growth factor stimulation(Moniz et 
al., 2011).. Nek10 physically associated with Raf-1 and MEK1 in a Raf-1-
dependent manner, and the formation of this complex was necessary for 
Nek10-mediated MEK1 activation. The appropriate maintenance of the G2/M 
checkpoint following UV irradiation required Nek10 expression and ERK1/2 
activation, indicating a role for Nek10 in the cellular response to UV 
irradiation. 
  
 30 
 
 
 
 
 
 
AIM OF THE STUDY 
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By yeast-two hybrid screening, we have identified PCM1 as a novel AKAP that 
binds a targets PKA in specific subcellular compartments. We also found that 
PCM1 binds the NIMA-related kinase10 (NEK10).  A functional PCM1-based 
multikinase complex, which includes PKA and NEK10,  was characterized and 
analyzed in mammalian cells. PCM1 is a scaffold protein mostly localized in 
centriolar satellites and in electron dense granules with a size ranging 
between 70 and 100 nm in diameter. PCM1 was initially identified for its cell 
cycle-dependent association with the centrosome complex and microtubules. 
Functional experiments revealed that PCM1 is essential for cell division and 
microtubule dynamics, playing a critical role in mitosis and ciliogenesis. 
Whether PCM1 could be involved in the regulation of PKA and NEK10 
signaling at the pericentriolar region and centrosomal area was unknown. 
During my PhD program, I attempted to address the role of PCM1 as scaffold 
protein that senses, transmits and integrates signals carried out by PKA and 
NEK10. Accordingly, the principal aims of my PhD thesis were the following: 
 identify PCM1 as a novel PKA anchor protein (AKAP) 
 map the PKA binding determinants on PCM1 
 characterize the PCM1-PKA complex in mammalian cells. 
 identify  NEK10 as novel partner of PCM1  
 study the regulation of PCM1-NEK10 complex formation and 
stability by PKA  
 determine the role of PCM1-kinase complex in the control of 
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ciliogenesis. 
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RESULTS 
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2.1 PCM1 and RIIβ form a stable complex 
 
To identify novel PKA interacting proteins, a cDNA library was screened by 
yeast two-hybrid using mouse full-length RIIβ as bait. One positive clone 
encoding for an open reading frame corresponding  to  human PCM1 was 
isolated. We investigated whether endogenous PCM1 and RIIβ subunit 
interact in cell extracts. Lysates from HEK293 cells were immunoprecipitated 
with anti-RII or non-immune IgG. Precipitates were immunoblotted with 
anti-RII or anti-PCM1 polyclonal antibody. As shown, we detected an 
endogenousPCM1-RII complex (fig. 5A). To confirm the binding between 
PCM1 and RIIβ subunits, HA-tagged PCM1 and Myc-tagged RIIβ were co-
expressed in HEK293 for 24 hours. As control, we used an empty vector 
(CMV). Total lysates were immunoprecipitated with anti-Myc antibody. 
Precipitates were immunoblotted with anti-RII or with anti-PCM1 polyclonal 
antibody. The data confirmed the existence of a PCM1-RII complex in cell 
lysates (Fig. 5B). 
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Figure 5. PCM1 binds PKA RII subunit.(A)Lysates (2mg) from HEK293 cells were 
immunoprecipitated with anti-RIIor non-immune IgG. Precipitates were 
immunoblotted with anti-RIIor anti-PCM1 polyclonal antibody.(B) CMV or PCM1-
HA and RIIβ-Myc were transiently transfected in HEK293 cells. Lysates were 
immunoprecipitated with anti-Mycand immunoblotted with anti-PCM1. 
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2.2  Endogenous PCM1 and RIIβ colocalize in Human Embryonic 
Kidney 293 cells. 
 
To demonstrate that PCM1 and RIIare located within the same 
compartment, we analyzed the localization of both proteins in Human 
Embryonic Kidney 293 cells (HEK293). To this end, we performed double 
immunofluorescence using anti-PCM1 and anti-RII antibodies. As suspected, 
the results indicate that PCM1 and RIIin part, colocalize at the Golgi-
centrosome region and pericentriolar matrix (Fig. 6). 
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Figure 6. PCM1 and RIIcolocalize in Human Embryonic Kidney cells 
(HEK293).HEK293 were subjected to double immunofluorescence with rabbit 
polyclonal anti-PCM1 and mouse monoclonal anti-RII antibodies.Immunostaining 
showing colocalization of PCM1 and RIIin human embryonic kidney  cells 
HEK293.Colocalization Pearson’s coefficient PCM1-RII. Scale bar: 20 m. 
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2.3  Mapping the PKA binding domain on PCM1 
 
The data above demonstrate that PCM1 and RIIβ form a stable complex in 
lysates and partly co-localize within the same subcellular compartment. To 
identify the domain of PCM1 that mediates the binding to RIIβ, we used 
vectors encoding for distinct segments of PCM1. To trace the recombinant 
polypeptides,  the hemoagglutinin epitope (HA) was placed at the NH2-
terminus of each construct. The HA-tagged PCM1 polypeptides used are the 
following: PCM1(741-1420)-HA, PCM1(1-740)-HA and PCM1(1421-2024)-HA. 
Recombinant polypeptides were co-expressed with Myc-RIIβ in HEK293 cells 
for 24 hours. Lysates were immunoprecipitated with goat anti-RIIβ. 
Precipitates were immunoblotted with anti-RII or anti-HA monoclonal 
antibody. We found that residues 741 to 1420 of PCM1 are sufficient for 
optimal binding to RIIβ (Fig. 7A).  
To further map the PKA binding domain on PCM1, we generated three 
polypeptides spanning distinct subdomains of the PCM1(741-1420)-HA 
construct:mid1-HA (residues 741-1007), mid2-HA (residues 967-1233) and 
mid3-HA (residues 1193-1420). The polypeptides were transiently expressed 
in HEK293 and the lysates subjected to cAMP-affinity puririfcation assays. The 
results revealed that mid1 and mid3 segments both retain the ability to bind 
RIIβ (Fig. 7B). This suggest the presence of two distinct RIIβ binding motifs on 
the middle segment of PCM1. 
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Figure 7.Mapping the RII binding domain on PCM1. A. HA-tagged recombinant 
fragments of PCM1-HA  (741-1420, 1-740, 1421-2024) and RIIβ were transiently 
transfected in HEK293 cells. Lysates subjected to immunoprecipitation with anti-RIIβ. 
The precipitates were immunoblotted for RIIβandHA. B. cAMP-agarose affinity 
purification of PKA complexes using lysates from HEK293 cells transiently transfected 
with HA-tagged PCM1 constructs and RIIβ-Myc. The specificity of the binding to 
cAMP-beads was verified by competing the PKA binding to the cAMP-agarose beads 
with high concentrations of free, uncoupled cAMP.  
 40 
 
2.4  PCM1  is an A-Kinase Anchor Protein  
 
To map the RIIβ-interacting motif on PCM1, overlapping 25-mer peptides 
derived from human PCM1 were spotted onto a membrane and overlaid with 
purified GST-RIIβ fusion protein, as previously described (Lignitto et al., 2011, 
2013) We identified five potential binding motifs located at the middle 
segments of PCM1(Fig. 8). Computational analysisof the RIIβ binding peptides 
indicates the presenceof potential amphipathic −helical wheels that may 
coordinate the binding to R subunits(Fig.8), as it occurs in prototypical AKAPs. 
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Figure 8. Identification of the RIIβ binding motif on PCM1. Overlapping 25-mer 
peptides derived from human sequence of PCM1 were spotted onto membranes and 
overlaid with purified GST-RIIβ fusion protein. The bound GST-RIIβ was visualized by 
immunoblottting the membranes with anti-GST antibody (upper panel).Positive 
signal present on duplicate membranes were further characterized. The sequence of 
the RIIβ binding peptides and the putative −helical wheels are shown (lower panels)  
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2.5 PCM1 silencing redistributes endogenous RIIβ subunits 
 
Next, we attempted to demonstrate that PCM1 is, indeed, mediating the 
localization ofRIIβ at the Golgi-centrosome compartment. To this end, we 
monitored the localization of RIIβin cells deprived of endogenous PCM1. 
HEK293 cells were transfected with control siRNAs or with siRNAs targeting 
endogenous PCM1. Forty-eight hours from transfection, cells were subjected 
to double immunofluorescence analysis with anti-PCM1 and anti-RII 
antibodies. As shown in Fig. 9,downregulation of PCM1diffusely redistributed 
RIIβ subunits fromthe Golgi-centrosome area to the cytoplasm, compared to 
controls (Fig. 9).These findings strongly suggest that PCM1, acting as an AKAP, 
positions PKAIIβ at the PCM area. 
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Figure 9.Silencing of PCM1 delocalizes RIIfrom the PCM area to the cytoplasm.A. 
HEK293 were transiently transfected with control siRNAs (SiCNT)or with siRNA 
targeting human PCM1 (SiPCM1). 24 hours from transfection, cells were fixed and 
doubly immunostained with anti-RIIand anti-PCM1 antibodies. Fluorescent images 
were collected and analyzed by confocal microscopy. B. Quantitative analysis of the 
experiments shown in A. The levels of PCM1 in siRNA transfected cells are shown. 
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2.6PCM1 interacts with NimA related kinase 10, Nek10 
 
Members of the NEK protein kianses have been implicated in the regulation of 
various aspects of centrosome stability, microtubule dynamics and cell cycle 
progression. In particular,NEK2is a cell cycle–regulated protein required for 
centrosome structure at the G2/M transition. Colocalization studies revealed 
that NEK2colocalizes with PCM1-containing centriolar satellites and depletion 
of PCM1 interferes with centrosomal recruitment of NEK2 (Hames et 
al.,2005). Another member of NEK family, NEK10, is also activated at G2/M 
transition and its activity is required for proper cell cycle progression.All this 
led us to investigate if NEKs, and in particular NEK10, might interact to PCM1. 
This mechanism would position another ser/thr kinase in close proximity of 
PKA within the same scaffold complex. NEK10-Flag vector was transiently 
transfected in HEK293 cells. Lysates were immunoprecipitated with anti-flag 
antibody or with non-immune IgG, and the precipitates were immunoblotted 
with anti-PCM1 and anti-flag antibodies. As shown in figure 10, PCM1 and 
NEK10 form a stable complex in cell lysates.  
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Figure 10.PCM1 interacts with NimA related kinase 10, Nek10.Lysates (2mg) from 
HEK293 cells transiently transfected with Flag-NEK10 were immunoprecipitated with 
anti-Flag or with non-immune IgG. Precipitates and a fraction (100 g) of lysates 
(WCE)were immunoblotted with anti-Flag or with anti-PCM1 polyclonal antibody. 
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2.7  Mapping the NEK10 binding domain on PCM1 
 
To identify the domain of PCM1 that mediates the binding to NEK10, we 
performed co-immunoprecipitation assays using the three segments of PCM1 
(PCM1(741-1420)-HA, PCM1(1-740)-HA and PCM1(1421-2024)-HA), described 
above.  The constructs were co-expressed with Flag-NEK10 in HEK293 cells for 
24 hours. Lysates were immunoprecipitated with anti-Flag antibody. 
Precipitates were immunoblotted with anti-Flag and anti-HA antibodies. The 
results show that NEK10 binds the middle segment of PCM1 (Fig. 11).  
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Figure 11. The segment spanning residues 741-1420 of PCM1binds to NEK10.PCM1-
HA constructs and NEK10-Flag were transiently transfected in HEK293 cells. Lysates 
were subjected to immunoprecipitation with Flag antibody. Precipitates and a 
fraction of lysates were immunoblotted with anti-Flag  or anti-HA. 
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2.8. PCM1, NEK10 and RIIβ colocalize at the Golgi-centrosome 
region 
 
Next, we demonstrated that PCM1, NEK10 and RIIβ are located within the 
same intracellular compartment. In particular ,we analyzed the localization of 
the trimeric complex by triple immunofluorescence assay usinganti-PCM1,  
anti-NEK10 andanti-RIIβ antibodies. As shown in Fig. 12, a colocalization signal 
of the three proteins could be detected at Golgi-centrosome region and 
pericentriolar matrix. 
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Figure 12.PCM1, NEK10 and RIIβ colocalize at the PCM region. HEK293cells were 
subjected to triple immunofluorescence with rabbit polyclonal anti-PCM1, goat 
polyclonal anti-NEK10 and mouse monoclonal anti-RIIβantibodies. A merge 
composite of the three  fluorescent signals is shown. 
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2.9 PKA regulates phosphorylation and binding of NEK10 to PCM1 
 
The data indicate that NEK10 and PKA interact with the middle segment of 
PCM1, suggesting a possible functional interaction between both kinases. 
Primary sequence analysis of NEK10 predicts the presence oftwo highly 
conserved PKA phosphorylation sites (Thr233 and Thr812) within the core 
region of the kinase(Fig. 13A). We postulated that PKA phosphorylates NEK10. 
We tested this hypothesis, by monitoring NEK10 phosphorylation by PKA in 
HEK293 cells transiently transfected with NEK10-flag and treated with 
forskolin, a cAMP elevating agent, for 30’ and 60'. Lysates were 
immunoprecipitated with anti-Flag antibody and the precipitates were, then, 
immunoblotted with antibodies that recognized phosphoSer/Thr PKA sites. 
The data indicate that NEK10is, indeed, phosphorylated in vivo by PKA(Fig. 
13B).  
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Figure 13.PKA phosphorylates NEK10. A. Schematic diagram of NEK10, including 
protein sequence surrounding the putative PKA consensus sites. Threonine 223 and 
Threonine 812 are underlined.B.HEK293 cells transiently transfected with NEK10-flag 
were serum deprived overnight and treated with forskolin (40 M) for 30 min and 
1h. Lysates were immunoprecipitates with anti-flag antibody and immunoblotted for 
the detection of phosphoSer/Thr PKA substrates and flag antibodies.  
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Next, we analyzed if PKA phosphorylation of NEK modulates its binding to 
PCM1. To this end, lysates from HEK293 cells, trasfected with NEK10-flag and 
treated with forskolin (15’, 30’, 1h),  were immunoprecipitated with anti-Flag 
or non-immune IgG. Precipitates were immunoblotted with anti-Flag or anti-
PCM1 polyclonal antibody. As shown in Fig. 14, PCM1-NEK10 complex 
formation wassignificantly affected by PKA stimulation.  
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Figure 14.Regulated binding of PCM1 to NimA related kinase 10  (Nek10) by cAMP 
signaling. NEK10-Flag  transiently transfected in HEK293 cells. Cells were serum 
deprived overnight and then treated with forskolin for 15’, 30’ and 1h.  Lysates were 
immunoprecipitated with anti-Flag antibodyand immunoblotted with anti-PCM1 or 
anti-Flag  antibodies. 
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We noticed that activation of PKA by forskolin also reduces the levels of 
NEK10, more evident at the later time points from forskolin stimulation (see 
Fig. 13B and Fig. 14). The effects of forskolin on NEK10 levels were abrogated 
by pre-treating the cells with the proteasomal inhibitor MG132. Moreover, 
treatment with MG132 increases the levels of NEK10 in unstimulated cells, 
compared to control. Altogether, these findings suggest that PKA 
phosphorylation of NEK10 reduces its binding to PCM1, inducing proteolysis 
of NEK10 through the ubiquitin-proteasome pathway(Fig.15). 
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Figure 15. PKA stimulation induces proteolysis of NEK10 through the ubiquitin-
proteasome pathway. HEK293 cells were transientlytransfected with NEK10-Flag, 
24hours from transfection, cells were treated for 6 hourswith MG132 (10M) and 
then, left untreated, or stimulated with forskolin for 1 hours  before harvesting. 
Lysates were immunoblotted with  anti-Flag or anti-Tubulin  antibodies. 
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2.10  NEK10 controls primary cilium formation 
 
Our findings indicate that NEK10 is a novel component of the PCM1-PKA 
complex and it is also a PKA substrate in living cells. Therefore, we asked if 
NEK10 contributes to the primary cilium assembly. To this end, HEK293 cells 
were transiently transfected with siRNA targeting endogenous NEK10 and 
serum deprived for 36 hours. The presence of cilium was revealed by using an 
antibody directed against the acetylated tubulin. This is a modified variant of 
tubulin that selectively accumulates along the cilium. Figure 16 shows that, in 
control (siRNAc) cells, serum deprivation significantly increased the number of 
primary cilia. By contrast, genetic knock-down of NEK10 drastically reduced 
both the length of primary cilia. As expected, re-expression of NEK10 reversed 
the effects of the siRNA-NEK10, indicating that NEK10 is, indeed, a biologically 
relevant player of ciliogenesis. 
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Figure 16. NEK10 controls primary cilium formation.  HEK293 were transiently 
transfected with control siRNA (SiCNT)or with siRNA targeting human NEK10 
(SiNEK10). 24 hours from transfection, cells were serum deprived for 36 hours to 
induce cilium formation. Cells were fixed and subjected to immunostaining analysis 
with anti-acetylated alpha tubulin and with anti-Flag antibodies (for NEK10-flag). 
Fluorescent images were collected and analyzed by confocal microscopy.  Arrows 
indicate the primary cilia. 
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DISCUSSION 
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PCM-1 is a scaffold protein that binds different proteins and mostly localizes 
to small 70–100-nm granules in the cytoplasm of interphase cells (Balczon et 
al., 1994; Kubo et al., 1999; Li et al., 2001).These granules can move along 
microtubules in a dynein-dependent manner and they are often concentrated 
near the microtubule organizing center (Balczon et al., 1999; Kubo et al., 
1999). Detailed morphological analysis revealed that the granules containing 
PCM1 are identical to structures previously described as “centriolar satellites” 
(Kubo et al., 1999).PCM1 is essential for cell division and microtubule 
dynamics, playing a critical role in different aspects of mitosis and ciliogenesis. 
The transition between centrosome and cilium, and the regulation of cell 
cycle are closely linked in normal dividing cells. Centrosomes, which are 
composed of two barrel-shaped centrioles surrounded by pericentriolar 
material, organize the cytoplasmic microtubule network, during interphase, 
and the bipolar spindle, during mitosis. In postmitotic cells, the centrosome 
migrates to the cell surface, and one of the centrioles differentiates into a 
basal body that nucleates microtubules to form a cilium. In normal 
proliferating cells, the presence of a cilium at the cell surface is transient and 
it is commonly observed in G1, disappearing during the progression through 
the cell cycle (Plotnikova et al., 2008).  
Several proteins, like PKA and NEK2,have been involved in the 
assembly/disassembly of primary cilium. Localization of PKA at the base of 
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primary cilium is essential for cilium growth. At the base of the cilium, PKA 
negatively regulates hedgehog (Hh) signal transduction pathway, as it is 
required for the proteolytic processing event that generates the repressor 
forms of the Ci and Gli transcription factors, keeping target genes off in the 
absence of Hh. Displacement of PKA from the ciliumby PKA-binding peptides that 
negatively impacts on primary cilium formation (Barzi et al., 2010). This 
strongly suggests the existence of a localized pool of PKA maintained at the 
base of cilium which targets Hh signaling during the essential steps of 
ciliogenesis. The question is: how cells maintain the high localized PKA activity 
at the cilium base? Here, we provide evidence that PCM1 by acting as an 
AKAP positions a pool of PKA (PKA-RIIβ) at the pericentriolar matrix, 
centrosome compartment and most likely at the base of cilium. Genetic 
knock-down of PCM1 delocalizes PKA from this area, diffusely distributing the 
kinase throughout the cytoplasm. The PKA binding domain was mapped 
within the middle segment of PCM1 (residues 741 to 1420).A combinatorial 
approach of computational analysis and in vitro binding assays allowed the 
identification of peptides mapping within the middle part of PCM1 that 
specifically interact with RIIβ. Some of the peptides are predicted to form 
amphypatic helical wheel that is a prerequisite for most of the PKA binding 
proteins. The biological role and contribution of the individual PCM1 peptides 
in PKA binding and ciliogenesis are currently under investigation. 
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Here, we also report that a member of the Nima-related kinases, NEK10, takes 
part of the PCM1 assembled complex at the pericentriolar matrix. NEK10 is a 
kinase that becomes activated at G2/M transition and its activity is required 
for proper cell cycle progression. We found that the middle segment of PCM1 
also binds NEK10, juxtaposing the mitotic kinase in proximity of PKA. Our 
results show that  PCM1, PKA and NEK10 form a trimeric complex at the same 
subcellular compartment, suggesting that PCM1 works as scaffold protein that 
receives and integrates signals from PKA and NEK10. Primary sequence 
analysis of NEK10 predicts the presence of two highly conserved PKA 
phosphorylation sites (Thr233 andThr812) within the core region of the 
kinase. Accordingly, we found that PKA efficiently phosphorylates NEK10 in 
living cells. Phosphorylation of NEK10 by PKA reduces its binding to PCM1, 
indicating the existence of a highly dynamic regulation of the multikinase 
complex assembled by PCM1. Furthermore, we found that PKA activation 
leads to proteolysis of NEK10 through the ubiquitin-proteasome system, 
suggesting a potential antagonism between PKA activation and NEK10. 
Importantly, we found that genetic downregulation of NEK10 severely 
affected the process of ciliogenesis, reducing the length and the number of 
mature primary cilia. Our working model predicts that activation of PKA at the 
pericentriolar matrix, by modulating the localization and the levels of 
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NEK10,negatively interferes with NEK10-mediated events during microtubule 
dynamics and ciliogenesis. 
In conclusion, we have identified a scaffold platform nucleated by PCM1 at 
the pericentriolar matrix and centrosome, which includes PKA and NEK10, 
that controls critical aspects of mammalian ciliogenesis. Within the PCM1 
complex, PKA controls NEK10 localization and  stability, efficiently coupling 
cAMP signaling to the ubiquitin-proteasome system (UPS). In this context, 
PCM1 acts as relay that senses, transmits and integrates cAMP and mitogenic 
signals generated at cell membrane, regulating biological events at the 
pericentriolar matrix area and primary cilium. 
Identifying relevant scaffold complexes at specific sub-cellular compartments 
and understanding the role of each component of this multi enzyme signaling 
cascade in critical aspects of cell biology will undoubtedly contribute to the 
design of novel approaches and tools for the treatment of several human 
diseases. 
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METHODS 
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Cell lines.Human embryonic kidney cell line (HEK293) was cultured in DMEM 
containing 10% fetal bovine serum (FBS) supplemented with 2mM L-
glutamine, 100 IU/ml penicillin, in an atmosphere of 5% CO2 at 37°C.  
Plasmids, siRNAs and transfection. Vectors encoding for wild typeHA-PCM1, 
HA-PCM1(1-740aa), HA-PCM1(741-1420aa) or HA-PCM1(1421-2024aa) were 
kindley provided from Dr Kamiya (Kamiya et al., 2008); flag-NEK10 were 
kindley provided from Dr Stambolic (Stambolic et al., 2011)); epitope Myc 
tagged RIIβ vectors were kindley provided by Dr Ginsberg SH (Lim et al., 
2007). Three different subdomains,mid1-HA (741-1007aa), mid2-HA (967-
1233a), mid3-Ha (1193-1420aa) were generated by PCR with specific 
oligonucleotide primers and subcloned into the same vector as HA-PCM1(741-
1420aa) cDNA. SMART pool siRNAs targeting coding regions of distinct 
segments of PCM1 and NEK10 were purchased from Dharmacon and IDT, 
Integrated DNA Technologies. The siRNAs were transiently transfected using 
Lipofectamine 2000 (Invitrogen) at a final concentration of 100 pmol/ml of 
culture medium. 
Antibodies and chemicals. Polyclonal antibodies directed against PCM1 were 
purchased from ABCAM and Cell Signalling, and used at working 1:1,000; 
rabbit polyclonal antibodies directed against phosphoPKA was purchased 
from Cell Signalling, and used at working diluition of 1:1000; goat antibodies 
directed against RIIβ was purchased from  Santa Cruz at working diluition of 
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1:1000; monoclonal antibodies directed against RIIβ was purchased from BD 
Transduction and used at working 1:2,000; haemagglutinin epitope (HA) was 
purchased from Covance and used at working diluition of 1:1000; monoclonal 
antibodies directed against flag and myc epitope used at working diluition 
1:3000,were purchased from Sigma; polyclonal antibodies directed against 
acetylated alpha tubulin was purchased from ABCAM. Forskolin was 
purchased from Sigma.  
Cell lysates and Immunoprecipitation. Cells were washed twice with 
phosphate-buffered saline and lysed in a RIPA buffer (50mM TRIS–hydrogen 
chloride, pH 7.4, 150mM sodium chloride, 5mM magnesium chloride, 5mM 
dithiothreitol, 1mM ethylene diamine tetraacetic acid, 1% Triton X-100,containing 
aprotinin (5 g/ml), leupeptin (10 g/ml), pepstatin (2 g/ml), Na3VO4 and 
1mM phenylmethylsulfonyl fluoride and protease inhibitors. The lysates were 
cleared by centrifugation at 15,000 g for 15 min. Cell lysates (2 mg) were 
immunoprecipitatedin rotation at 4 °C overnight with the indicated 
antibodies. Pellets were washed four times in lysis RIPA buffer supplemented 
with NaCl (0.4 M final concentration) and eluted in Laemly buffer.An aliquot 
of whole cell lysates (WCE) (100 g) or immunoprecipitates were resolved on 
sodium dodecyl sulfate polyacrylamide gel and transferred on nitrocellulose 
membrane (Biorad, Milan, Italy) for 3 h. Filters were blocked for 1 h at room 
temperature in Tween-20 Phosphate buffer saline (TPBS) (PBS- Sigma, 0,1% 
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Tween 20, pH 7.4) containing 5% non-fat dry milk. Blots were then incubated 
O/N with primary antibody. Blots were washed three times with TPBS buffer 
and then incubated for 1 h with secondary antibody (peroxidase-coupled anti 
rabbit (GE-Healthcare) in TPBS. Reactive signals were revealed by enhanced 
ECL Western Blotting analysis system (Roche).  
Immunofluorescence and confocal analysis. For immunofluorescence studies, 
HEK293 cells transiently transfected with the expression vectors were plated 
on poly-L-lysine (10µg/ml) coated glass coverslips. Cells were fixed with 
Paraformaldehyde for 20 minutes. After three washes, cells were 
immunostained with polyclonal antibodies directed against PCM1 was 
purchased from ABCAM, and used at working diluitions of 1:100; monoclonal 
antibodies directed against RIIβ was purchased from BD Transduction and 
used at working diluition of 1:400 monoclonal antibodies directed against Flag 
epitope used at working diluition of 1:400; polyclonal antibodies directed 
against  acetylated alpha tubulin was purchased from ABCAM and used at 
working diluition of 1:100. Immunofluorescence was visualized using a Zeiss 
LSM 510 Meta argon/krypton laser scanning confocal microscope. 
Quantification of the immunofluorescent images and correlation (Pearson's) 
coefficient were calculated by Image-J software.  
cAMP precipitation. β2AR HEK293 cells transiently overexpressing PCM1-
mid1-HA (741-1007aa), PCM1-mid2-HA (967-1233a) orPCM1-mid3-Ha (1193-
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1420aa) fusion proteins have been treated with indicated stimuli, were lysed 
and subjected to precipitations with Rp-8-AHA-cAMP agarose resin (Biolog) 
for two hours. In this assay, binding of R subunits to the resin-coupled cAMP 
analogue (= PKA inhibitor Rp-cAMP, inhibits holoenzyme dissociation) results 
in re-association of activated PKAc and R subunits. To test the impact of cAMP 
on the complex formation of PKA•PCM1-mid1-HA (741-1007aa), PKA•PCM1-
mid2-HA (967-1233a) orPKA•PCM1-mid3-Ha (1193-1420aa)  we artificially 
elevated endogenous cAMP levels with forskolin or through activation of the 
stably expressed beta2-adrenergic receptor (β2AR) by isoproterenol prior to 
cell lysis. As control we have added excess of cAMP (5mM) to mask the cAMP 
binding sites in the R subunits for precipitation. Resin associated complexes 
have been washed at least four times with the lysis buffer (10 mM sodium 
phosphate pH 7.2, 150 mMNaCl, 0,5% Triton X100 supplemented with 
standard protease inhibitors) and eluted with Laemmli sample buffer and 
subjected to immunoblot analysis.  
StatisticsData were analysed using analysis of variance (ANOVA) for each 
region and post hoc repeated-measure comparisons (Least Significant 
Difference (LSD) test). Rejection level was set at P < 0.05. 
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